From last weeks ann:
The Phase II clinical trial of ATL1103 in acromegaly patients continues on track. Applications for
approval to conduct the clinical trial have been made in the UK, France and Spain. Relevant Ethics
Committee and Regulatory approvals have been received in the UK, the main location for recruiting
patients into the trial. One final step of trial approval in the UK is anticipated by early December,
which would allow patient recruitment to commence before the end of the year, as per previous
guidance.
Back in.
- Forums
- ASX - By Stock
- PER
- uk trial approval behind line wipe ?
uk trial approval behind line wipe ?
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
0.004(4.94%) |
Mkt cap ! $76.63M |
Open | High | Low | Value | Volume |
8.1¢ | 8.5¢ | 8.1¢ | $46.54K | 563.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 164616 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 100110 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 164616 | 0.081 |
5 | 215500 | 0.080 |
1 | 250000 | 0.079 |
3 | 71500 | 0.078 |
2 | 121300 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 100110 | 1 |
0.087 | 125000 | 1 |
0.089 | 102263 | 2 |
0.090 | 146175 | 1 |
0.091 | 108000 | 1 |
Last trade - 15.55pm 28/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online